These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3228593)

  • 1. Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.
    Bertelli G; Pronzato P; Amoroso D; Cusimano MP; Conte PF; Montagna G; Bertolini S; Rosso R
    Breast Cancer Res Treat; 1988 Dec; 12(3):307-10. PubMed ID: 3228593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
    Ilanchezhian S; Thangaraju M; Sachdanandam P
    Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III.
    Jordan VC; Fritz NF; Tormey DC
    Cancer Res; 1987 Aug; 47(16):4517-9. PubMed ID: 3607780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
    Esteva FJ; Hortobagyi GN
    Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen treatment of metastatic breast cancer and antithrombin III levels.
    Enck RE; Rios CN
    Cancer; 1984 Jun; 53(12):2607-9. PubMed ID: 6426771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
    Saarto T; Blomqvist C; Ehnholm C; Taskinen MR; Elomaa I
    J Clin Oncol; 1996 Feb; 14(2):429-33. PubMed ID: 8636753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels.
    Babu JR; Sundravel S; Arumugam G; Renuka R; Deepa N; Sachdanandam P
    Cancer Lett; 2000 Apr; 151(1):1-5. PubMed ID: 10766415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamoxifen on blood coagulation.
    Auger MJ; Mackie MJ
    Cancer; 1988 Apr; 61(7):1316-9. PubMed ID: 3345487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
    Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
    Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
    Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
    Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.
    Love RR; Newcomb PA; Wiebe DA; Surawicz TS; Jordan VC; Carbone PP; DeMets DL
    J Natl Cancer Inst; 1990 Aug; 82(16):1327-32. PubMed ID: 2199681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy.
    Love RR; Surawicz TS; Williams EC
    Arch Intern Med; 1992 Feb; 152(2):317-20. PubMed ID: 1739360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?
    Gaibar M; Fernández G; Romero-Lorca A; Novillo A; Tejerina A; Bandrés F; Fernández-Santander A
    Int J Biol Markers; 2013 Dec; 28(4):e371-6. PubMed ID: 23828408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.
    Wasan KM; Goss PE; Pritchard PH; Shepherd L; Tu D; Ingle JN
    Breast Cancer Res Treat; 2012 Dec; 136(3):769-76. PubMed ID: 23089983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen use, oestrogen binding and serum lipids in postmenopausal women with breast cancer.
    Ingram D
    Aust N Z J Surg; 1990 Sep; 60(9):673-5. PubMed ID: 2396945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia.
    Nóvoa FJ; Boronat M; Carrillo A; Tapia M; Díaz-Cremades J; Chirino R
    Horm Res; 2002; 57(5-6):187-91. PubMed ID: 12053091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancer.
    Thangaraju M; Kumar K; Gandhirajan R; Sachdanandam P
    Cancer; 1994 Feb; 73(3):659-63. PubMed ID: 8299087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
    Tominaga T; Kimijima I; Kimura M; Takatsuka Y; Takashima S; Nomura Y; Kasumi F; Yamaguchi A; Masuda N; Noguchi S; Eshima N
    Jpn J Clin Oncol; 2010 Jul; 40(7):627-33. PubMed ID: 20382637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.